MD Anderson Cancer Center
Chronic Lymphocytic Leukemia (CLL) Moon Shot update - CNL
Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Transcript Transcript     Accessibility shortcut keys (H) Shortcuts
Loading the Audio Player...

Title: Chronic Lymphocytic Leukemia (CLL) Moon Shot update - CNL
Summary: Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.
Keywords: cnl, cancer newsline, moon shot, Chronic Lymphocytic Leukemia, cll, Michael keating, immune system, Immunotherapy, treatment, research
Transcript: http://www.mdanderson.org/transcripts/cancer-newsline/2014/chronic-lymphocytic-leukemia-moon-shot-cll-update-8-7-14.htm